pm http www.pharmacosmos.com recent newsaugust 19 2016pharmacosmos to initiate large scale clinical study programme in support of monofer iron isomaltoside us fda approval while searching for a commercial us partneraugust 15 2016pharmacosmos launches new website on novel cryoprotectant pentaisomaltose june 7 2016first ever hard endpoint randomised controlled trial looking at effect of intravenous iron monofer iron isomaltoside in chronic heart failure about to start committed to quality pharmacosmos develops and markets medicines for the treatment of iron deficiency . an independent pharmaceutical company with an ongoing r & d programme our goal is to improve iron therapy options for patients and healthcare professionals . our second focus area we develop and market high quality dextran biopolymers for pharmaceutical and life science products . read more about our company and our products . our brandssee all brands read about monofer read about diafer read about cosmofer read about uniferon read about dextran pharmacosmos a s roervangsvej 30 dk 4300 holbaek t 45 59 48 59 59 e info pharmacosmos.com disclaimer privacy statement about this site 2016 pharmacosmos a s this website contains information on products which is targeted to a wide range of audiences outside us and may contain product details or information otherwise not accessible or valid in your country . please be aware that we do not take any responsibility for accessing such information which may not comply with any legal process regulation registration or usage in the country of your origin . monofer cosmofer and uniferon are a registered trademarks of pharmacosmos a s. all rights reserved .